2.9.1.2 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29464431&form=6&db=m A SEPSECS mutation in a 23-year-old woman with microcephaly and progressive cerebellar ataxia. causal interaction,ongoing research,unassigned 2,1,0 2.9.1.2 Microcephaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29464431&form=6&db=m A SEPSECS mutation in a 23-year-old woman with microcephaly and progressive cerebellar ataxia. causal interaction,ongoing research,unassigned 2,1,0 2.9.1.2 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16521218&form=6&db=m Characterization of human gene encoding SLA/LP autoantigen and its conserved homologs in mouse, fish, fly, and worm. unassigned - 2.9.1.2 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29709707&form=6&db=m Consequences of mutations and inborn errors of selenoprotein biosynthesis and functions. causal interaction,unassigned 4,0 2.9.1.2 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28690845&form=6&db=m Diagnostic autoantibodies for autoimmune liver diseases. causal interaction,unassigned 1,0 2.9.1.2 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12117891&form=6&db=m Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. diagnostic usage,therapeutic application,unassigned 2,1,0 2.9.1.2 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28810614&form=6&db=m Evolution of correlation between Helicobacter pylori infection and autoimmune liver disease. diagnostic usage,unassigned 2,0 2.9.1.2 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11826415&form=6&db=m Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas. causal interaction,diagnostic usage,unassigned 4,4,0 2.9.1.2 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20623998&form=6&db=m Human SepSecS or SLA/LP: selenocysteine formation and autoimmune hepatitis. causal interaction,ongoing research,therapeutic application,unassigned 4,4,1,0 2.9.1.2 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10801173&form=6&db=m Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,1,0